Stoneridge Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$6.5M |
| 2 |
Gilead Sciences
GILD
|
+$5.52M |
| 3 |
Delta Air Lines
DAL
|
+$4.91M |
| 4 |
Emerson Electric
EMR
|
+$4.51M |
| 5 |
Medtronic
MDT
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$9.69M |
| 2 |
Apple
AAPL
|
+$5.78M |
| 3 |
Ally Financial
ALLY
|
+$3.27M |
| 4 |
Target
TGT
|
+$3.25M |
| 5 |
United Parcel Service
UPS
|
+$3.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.25% |
| 2 | Financials | 16.04% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Healthcare | 11.13% |
| 5 | Communication Services | 10.17% |
Similar funds
Stoneridge Investment Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Stoneridge Investment Partners held 150 positions worth $340M, up 6.5% from $319M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Stoneridge Investment Partners withdrew a net $10.5M in Q1 2019, closing 39 positions and reducing 49 holdings. Its most notable exit was Ally Financial, an estimated $3.27M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Stoneridge Investment Partners opened a new position in Capital One worth $6.53M.
- Stoneridge Investment Partners's largest Q1 2019 buy was Capital One: 79,932 shares worth $6.53M.
- Stoneridge Investment Partners added most to Verizon in Q1 2019, an estimated $2.49M increase.
- Stoneridge Investment Partners's biggest Q1 2019 reduction was Biogen, cutting an estimated $9.69M.
- Stoneridge Investment Partners fully exited Ally Financial in Q1 2019, selling an estimated $3.27M.
- Stoneridge Investment Partners's ten largest holdings make up 27% of its $340M portfolio in Q1 2019.
- Stoneridge Investment Partners opened 31 new positions and closed 39 in Q1 2019.
- Stoneridge Investment Partners's portfolio value rose 6.5% quarter-over-quarter to $340M.
Based on Stoneridge Investment Partners's 13F filing for Q1 2019, filed 25 Apr 2019.